11/12/2025 16:05
UBS lowered the target price for Giant Biogene (02367) to HKD39.5 from HKD79.5 and downgraded the rating to "neutral" from "buy".
The research house said it is turning more cautious about the near-term sales growth outlook and expects Giant Biogene's sales growth to decelerate to 5% during 2026-28.
【說說心理話】如何從小孩子的行為察覺他們心理上有壓力？播道兒童之家院長個案分享► 即睇
上一篇新聞︰12/12/2025 14:40 {I-bank focus}Morgan raises COSCO Ship Hold to HKD10.3
下一篇新聞︰11/12/2025 14:32 {I-bank focus}J.P. Morgan lowers Brilliance Chi to HKD4.1
15/12/2025 16:00 {I-bank focus}Citi raises Li Ning (02331) to HKD20.6
15/12/2025 14:35 {I-bank focus}Morgan raises Ali Health (00241) to HKD4.6
12/12/2025 16:08 {I-bank focus}Citi lowers China Res Power (00836) to HKD19
09/12/2025 16:02 {I-bank focus}Citi lowers HKEX (00388) to HKD505
09/12/2025 15:10 {I-bank focus}Citi raises Brilliance Chi (01114) to HKD4.8
